LitAlert ~~ GeneLit.com

    • Homologous Recombination Deficiency (HRD) and BRCA 1/2 Gene Mutation for Predicting the Effect of Platinum-Based Neoadjuvant Chemotherapy of Early-Stage Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis.
    • Chai Y, Chen Y, Zhang D, Wei Y, Li Z, Li Q, Xu B.
    • J Pers Med. 2022 Feb 21;12(2):323. doi: 10.3390/jpm12020323.
    • Co-Relation of Hormonal Profile and BRCA1 in Sporadic Breast Carcinoma: A Single Institutional Experience of 303 Patients.
    • Agarwal P, Khan F, Gupta S, Bhalla S, Thomas A, Anand A, Singh K, Sonkar AA.
    • Clin Pathol. 2022 Feb 14;15:2632010X221076379. doi: 10.1177/2632010X221076379.
    • Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients.
    • Macchini M, Centonze F, Peretti U, Orsi G, Militello AM, Valente MM, Cascinu S, Reni M.
    • Cancer Treat Rev. 2022 Feb 10;104:102357. doi: 10.1016/j.ctrv.2022.102357. Epub ahead of print.
    • Review
    • Background splicing as a predictor of aberrant splicing in genetic disease.
    • Alexieva D, Long Y, Sarkar R, Dhayan H, Bruet E, Winston Rm, Vorechovsky I, Castellano L, Dibb NJ.
    • RNA Biol. 2022 Jan;19(1):256-265. doi: 10.1080/15476286.2021.2024031.